TCTR20210928005Unknown4 期
Efficacy of VAB (Vonoprazan, Amoxicillin and Bismuth subsalicylate) versus standard triple therapy for Helicobacter pyroli eradication: A randomized controlled trial
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Age > 20 years, Postive test of H. pylori infection (Urea breath test, Stool Ag test, EGD with Rapid urease test or Tissue pathology) with agreement
排除标准
- •Active upper gastrointestinal bleeding, eGR < 30 ml/min/1.73m2, drug allergy, pregnancy or lactation, hemodynamic instability, previous treatment of H. pylori infection, HIV infection, Neuroendocrine tumor
研究者
相似试验
招募中
不适用
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp EradicationHelicobacter Pylori EradicationNCT06349486Kaohsiung Medical University390
招募中
不适用
Comparison of Dual Amoxicillin/Vonoprazan Therapy and Triple Vonoprazan/Amoxicillin/Clarithromycin or Metronidazole Therapy for H. Pylori EradicatioH. pylori infectionJPRN-UMIN000022963Hamamatsu University School of Medicine100
尚未招募
3 期
Efficacy of Vonoprazan, Sitafloxacin and Amoxicillin Regimen for Treatment of Refractory Helicobacter pylori infectioPrevalence of helicobacter pylori is 17-55%. Ten to twenty percents of H.pylori infection were failed to treatment with first line regimen. Refractory H.pylori infection defined as H.pylori infection which failed to treatment with at least 2 regimens. There was not standard regimen for H.pylori infection.Refractory Helicobacter pylori, Helicobacter pylori, Resistant Helicobacter pyloriTCTR20211203002Routine to Research Unit, Siriraj Hospital20
尚未招募
4 期
Treatment regimen in Refractory Helicobacter pylori infectioPatients with refractory Helicobacter pylori infectionHelicobacter pyloriTreatment regimenTreatment failureTCTR20200910007Division of gastroenterology, Faculty of Medicine, Siriraj Hospital, Mahidol University20
已完成
4 期
Efficacy and Safety of Dual Therapy for Helicobacter Pylori EradicationHelicobacter Pylori InfectionNCT05469685Nanjing First Hospital, Nanjing Medical University914